Soft tissue sarcoma - Treatment with radium-224 Factor
Last reviewed for CCPS 20 August 2008.
Preliminary questions [30648]
30651 there is some evidence that treatment with radium-224 may be a factor in the development of the condition under consideration.
30652 the veteran has received treatment with radium-224 at some time.
30656 the veteran received treatment with radium-224 as treatment for an illness or injury which is identifiable.
30653 — the veteran has established the causal connection between receiving treatment with radium-224 and VEA service for the clinical onset of soft tissue sarcoma.
30650 — the veteran has established the causal connection between receiving treatment with radium-224 and eligible service for the clinical onset of soft tissue sarcoma.
or
30649 — the veteran has established the causal connection between receiving treatment with radium-224 and operational service for the clinical onset of soft tissue sarcoma.
Clinical onset and operational service [30649]
for the identified illness or injury, the veteran received treatment with radium-224 at least two years before the clinical onset of the condition under consideration.30659 — the identified illness or injury for which treatment with radium-224 was received is causally related to operational service.
Clinical onset and eligible service [30650]
for the identified illness or injury, the veteran received treatment with radium-224 at least five years before the clinical onset of the condition under consideration.30660 — the identified illness or injury for which treatment with radium-224 was received is causally related to eligible service.